Zhittya Genesis Medicine’s marketing partner for the U.S. and Canada is doing an IPO. Zhittya is working on the number one cause of death in the world which are diseases that are caused by a lack of blood flow: heart disease, stroke, Parkinson’s disease, Type 2 diabetes and more. This presentation you will explore how Zhittya is using their FGF-1 to treat these diseases and how Zhittya’s marketing partner’s pending IPO will create a great opportunity for investors.
Speakers
Daniel Montano
CEO, Zhittya Genesis Medicine, Inc.